Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Treace Medical Concepts Stock Quote

Treace Medical Concepts (NASDAQ: TMCI)

$10.70
(-1.5%)
-$0.16
Price as of April 24, 2024, 10:51 a.m. ET

Treace Medical Concepts Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
TMCI -58.44% -57%
S&P +21.22% +71.17% +11.35% +21%

Treace Medical Concepts Company Info

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.